Short answer: A peptide vial is a small container closure system. It usually has a glass vial, a rubber (elastomeric) stopper, and an aluminum crimp cap that holds the stopper in place [1][10]. When a peptide is supplied freeze-dried (lyophilized), the vial also holds a dry cake, and the stopper is pushed fully closed inside the freeze-dryer [7]. Each part does a job. The glass has to resist chemical attack, the stopper and seal have to keep air and water vapor out, and the dry cake has to stay dry [1][4][9].
This article is educational chemistry and packaging science for research readers. It does not cover dosing, health effects, or use in people or animals.
What counts as a "vial" in packaging terms
The U.S. Food and Drug Administration's 1999 guidance on container closure systems sets out the vocabulary. A packaging component is any single part of a container closure system. Typical components include containers such as ampules, vials, and bottles; closures such as screw caps and stoppers; stopper overseals; and container labels [1]. A primary packaging component is or may be in direct contact with the contents. A secondary one is not [1]. The container closure system is the sum of the components that together contain and protect the product [1].
For a peptide vial, the glass and the stopper are primary components because they touch the peptide. The aluminum overseal and the printed label are not in contact with it [1]. In August 2026, FDA published a new draft guidance on container closure systems for comment. It is marked not for implementation [2], so this article uses the terms from the 1999 guidance.
The glass: Type I borosilicate
FDA's guidance says vials, cartridges, syringes, and ampules are usually made of Type I or Type II glass, or of polypropylene [1]. United States Pharmacopeia (USP) monographs for sterile products can name the material too. FDA quotes the example "preferably of Type I glass, protected from light" [1]. The relevant USP general chapters include 660, Glass Containers Used in Pharmaceutical Packaging/Delivery Systems, and 1660, Evaluation of the Inner Surface Durability of Glass Containers [3].
Type I glass is borosilicate glass [4][5]. A 2014 study in AAPS PharmSciTech notes that Type I borosilicate has a long, successful history as a pharmaceutical packaging material [5]. It also describes two subcategories, commonly called Type IA and Type IB. They differ in bulk glass chemistry and in thermal coefficient of expansion, and vials are commonly made from both [5]. A 2010 Eli Lilly study describes one of its test vials as a sodium borosilicate Type I glass "similar to Pyrex" [4].
How a tubing vial is formed
Tubing vials are made from glass tubing (cane). For tubing vials, heat is applied to cut and part the cane, then to tool the neck, and finally to form and polish the bottom. The bottom gets the most extreme heat. Earlier vial studies found that the region just above the bottom is more prone to delamination [5]. The same paper notes that vial manufacturing conditions can create glass defects that leave a less chemically resistant surface [5].
Surface treatments
Vial makers sometimes treat the inner surface. The Lilly study compared three vial types: a Type I vial treated inside with ammonium sulfate to reduce surface alkalinity, an untreated Type I vial, and a Type I vial with an extra internal silicon dioxide (SiO₂) coating applied by chemical vapor deposition [4]. The 2014 paper cites work finding that ammonium sulfate treatment can leave a degraded surface structure with extensive pitting [5].
Glass delamination: the main glass risk
Glass delamination is the release of glass flakes, or lamellae, from a glass surface [5]. In 2011 FDA issued an advisory to drug manufacturers about glass lamellae in drugs filled in small-volume glass vials, after several recalls in 2010 and 2011 [6]. The advisory linked higher rates of lamellae to several conditions [6]:
- Vials made by the tubing process at higher heat
- Solutions formulated at high pH
- Longer contact time between the product and the glass
- Terminal sterilization
Several of these risk factors describe a solution in contact with glass over time, such as pH and contact duration [4][6]. Once a peptide is dissolved in the vial, those factors become relevant. FDA's 2024 guidance on glass vial and stopper changes lists glass delamination, particulate matter, leachables, and the effect of the lyophilization process among the product-specific risks a manufacturer may need to study [3].
The stopper: elastomer chemistry and moisture
Stoppers and septa in vials are typically made of elastomeric (rubber) materials [1]. For these components, FDA typically treats data showing that a stopper meets USP Elastomeric Closures for Injections (general chapter 381) as sufficient evidence of safety [1][3]. FDA's 2024 guidance stresses that a container closure system's suitability depends on all of its components and on how they interact with the formulation over its shelf life, not only on the container [3].
Lyophilization stoppers
Vials that will be freeze-dried are closed in two stages. According to FDA's inspection guide on lyophilization, the vials are filled and partially stoppered under aseptic conditions, loaded into the freeze-dryer, frozen, and dried under vacuum. Complete stoppering then takes place inside the lyophilizer, usually by hydraulic or screw-rod mechanisms [7]. The same guide mentions a nitrogen system used for backfilling [7].
Moisture from and through the stopper
A stopper can be a source of water. Templeton and colleagues at Merck measured moisture in 20 mm bromobutyl rubber stoppers as received, after steam sterilization, after different drying cycles, and during simulated hold conditions. They found general agreement between stopper drying conditions and the moisture level of the lyophilized cake during storage [8].
A 2010 study by Sasaki and colleagues at Chugai separated two effects. Early in storage, moisture rose inside lyophilized vials because water moved out of the stoppers. Later, the rise came from outside moisture permeating through the stoppers. Permeation appeared to depend on the elastomer formulation. The study used humid storage conditions. For room-temperature storage, the authors called the stopper's moisture permeability one of the most important factors for long-term stability [9]. That matters for a dry peptide cake. See Lyophilized Peptides Explained for why water drives degradation.
The crimp seal: holding it all together
Pharmaceutical vials are typically closed with an elastomeric stopper secured by an aluminum crimp cap, or seal [10]. Residual seal force (RSF) is the compression force the crimp cap exerts on the stopper [10]. A 2019 study by Ovadia and colleagues found that RSF values varied significantly. For the configurations they tested, the root cause was dimensional tolerances in the packaging components. Container closure integrity (CCI), tested by helium leak, held even in loosely capped vials with no measurable RSF. The authors traced this to the stopper's two sealing surfaces, the valve seal and the land seal [10].
FDA's guidance makes a related point. Glass is relatively impermeable, but a glass container only protects better than plastic if there is a good seal between the container and the closure [1]. The guidance lists common causes of quality loss: light, solvent loss, reactive gases such as oxygen, water vapor, and microbial contamination [1]. Light protection is typically provided by an opaque or amber-colored container, or by opaque secondary packaging such as a carton [1].
The dry cake inside
FDA's inspection guide defines lyophilization (freeze-drying) as removing water from a product after it is frozen and placed under vacuum. The ice changes directly from solid to vapor without passing through a liquid phase. The process has three stages: freezing, primary drying (sublimation), and secondary drying (desorption) [7]. Listed advantages include enhanced stability of a dry powder and rapid, easy dissolution of the reconstituted product [7].
The guide treats cake appearance as a critical inspection point. One major concern is meltback, a form of cake collapse caused by incomplete sublimation in the vial. Meltback can come with a change in the physical form of the drug substance or a pocket of moisture, which may lead to greater instability [7]. A collapsed or partly melted-looking cake is worth noting when a vial arrives. For storage after receipt, see How to Store Research Peptides and the Peptide Storage Guide.
Vial walls and dissolved peptides
Once a peptide is in solution, the container wall becomes part of the experiment. Kristensen and colleagues used analytical HPLC to measure how three cationic peptides (mastoparan X, melittin, and magainin 2) adsorbed to borosilicate glass vials, polypropylene tubes, and Protein LoBind tubes. At typical experimental concentrations, 90% or more of the peptide could be lost from solution by rapid adsorption to container walls [11]. At low concentrations in the glass vials and polypropylene tubes, only 10–20% of the expected peptide was recovered. Losses in the Protein LoBind tubes were smaller [11].
Goebel-Stengel and colleagues tested eight radiolabeled peptides in glass and plastic tubes, with and without siliconizing treatment. They found important differences in binding between surfaces. Siliconization lowered recovery for most of the peptides tested, and adding bovine serum albumin (BSA) improved recovery [12]. Their conclusion: choosing the right container avoids unpredictable peptide loss that can lead to inaccurate measurements [12]. The practical point is that no single vial material is best for every peptide. Container choice is worth checking for quantitative work. For concentration math, see Peptide Calculator Explained. For dissolving lyophilized material, see How to Reconstitute Research Peptides.
A simple lab checklist for a received vial
These checks follow from the points above. They do not replace analytical testing.
- Seal: The aluminum crimp is intact and the stopper is seated. Glass protects well only when the seal is good [1][10].
- Cake: The cake looks uniform, without obvious meltback or collapse [7].
- Glass: There are no visible glass flakes. Delamination is better judged by flakes on the inner surface than by visible particles, so a clear look is not proof of a sound surface [4].
- Label: The lot number on the label matches the certificate of analysis. See How to Read a Peptide COA.
- Storage: Keep the vial in its carton or out of light if the material is light-sensitive [1].
FAQ
What is a peptide vial made of? Usually Type I borosilicate glass with an elastomeric stopper and an aluminum crimp cap [1][5][10]. FDA's guidance notes that vials may also be Type II glass or polypropylene [1].
What is the difference between Type IA and Type IB glass? Both are Type I borosilicate. They differ in bulk chemistry and thermal coefficient of expansion, and vials are made from both [5].
Why are peptide vials stoppered inside the freeze-dryer? In the standard process, vials are partially stoppered before freeze-drying. Complete stoppering happens inside the lyophilizer, usually by a hydraulic or screw-rod mechanism [7].
Can a rubber stopper add moisture to a dry peptide? Yes. Studies found water moving from stoppers into lyophilized products during storage, and later moisture permeating through the stopper from outside [8][9].
Do peptides stick to glass vials? They can. Cationic peptides lost 90% or more from solution to borosilicate glass and polypropylene at typical concentrations in one study [11]. Recovery depends on both the peptide and the surface [12].
Bottom line
A peptide vial is a small engineered system, not just a glass tube. The glass is usually Type I borosilicate [1][5], and forming heat, surface treatments, pH, and contact time all affect delamination risk [4][5][6]. The elastomeric stopper is seated inside the freeze-dryer [7], and its drying and formulation affect how much moisture reaches the cake [8][9]. The aluminum crimp holds the stopper's seals in place [10]. Once the peptide is dissolved, the vial wall can adsorb it [11][12]. Knowing these parts makes it easier to judge a vial on arrival and to choose the right container for the experiment.
All products are for research use only — not for human or animal consumption.